Delayed cord clamping ‘best treatment’ for cutting preterm infant mortality
Preterm infants are 32% less likely to die with delayed versus immediate umbilical cord clamping, according to Australian researchers who say their findings will inform…
Article Type: Specialist Update
Osimertinib-chemo combo boosts progression-free survival in EGFR-mutated lung cancer: study
Adding chemotherapy to oral osimertinib in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer prolongs progression-free survival by up to nine months,…
Offer salpingo-oophorectomy with C-section in BRCA mutation carriers: gynaecologists
Prophylactic bilateral salpingo-oophorectomy should be offered at time of obstetric-indicated caesarean delivery in women with the BRCA1 or BRCA2 pathogenic variants, say UK gynaecologists. In…
Add-on biologic a boon for kids with moderate to severe asthma: study
Fortnightly dupilumab with standard therapy leads to rapid and sustained improvements in asthma control for 6-11 year-olds with moderate to severe type 2 asthma, research…
COSA’s 50th ASM: Dr Belinda Yeo talks metastatic breast cancer, fertility and AI in oncology
On Wednesday, hundreds of Australian and overseas doctors will attend the opening of the Clinical Oncology Society of Australia’s 50th Annual Scientific Meeting in Melbourne.…
Asthma medication use in pregnancy ‘does not impair neurodevelopment in kids’
Corticosteroids and beta2 agonists are safe to use during pregnancy to manage asthma, say Japanese researchers who found no major impact of anti-asthmatic exposure on…
New NSCLC standard of care? Perioperative immunotherapy trial improves outcomes
Perioperative durvalumab in combination with chemotherapy should be considered as a potential new treatment option for resectable non-small cell lung cancer, according to US oncologists.…
Progression-free survival overused for cancer drug approvals, oncologists warn
Progression-free survival is a poor surrogate for overall survival and should not be relied upon as a primary endpoint for registration and marketing of anticancer…
Diabetes in NAFLD drives high rate of decompensated cirrhosis: Aussie study
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows. Age, hypertension and extrahepatic cancer all…
Older age should not preclude adjuvant therapy post-CRC resection: Aussie doctors
Over-80s with colorectal cancer are far less likely to receive adjuvant chemotherapy than younger patients despite having similar oncological and post-resection outcomes, Australian doctors say. Their…
